Singh Ajit, Khera Kanav, Agarwal Jatin, Awasthi Shivanshu, Francis Jewel M, Thunga Girish, Bhat Rama
Department of Cardiology, Kasturba Medical College & Hospital, Manipal University, Manipal-576104, India.
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal-576104, India.
Infect Disord Drug Targets. 2017;17(2):106-115. doi: 10.2174/1871526517666170407155558.
H1N1 (hemagglutinin-H-neuroaminidase-N) influenza infection is associated with high morbidity and mortality because of associated complications and related factors. Predictors of mortality in H1N1 patients are studied with very few without seasonal/pandemic declaration. This study was carried out to describe the clinical features, complications and different risk factors that affect the outcome in the patients with confirmed H1N1influenza infection.
A retrospective study was done in Kasturba Medical College Hospital, Manipal, India by analyzing the medical records of 141 patients admitted from January, 2011 to June, 2015.
Of the 141 patients in the study, 51.1% of the patients were female with a mean age of 32±16.2 years. Fever with headache was observed in 92.9% patients while cough in 78.7% patients and breathlessness in 54.6% patients. On the basis of disease severity, 53.2% of the patients were put on mechanical ventilation. For all the patients, treatment for influenza management began with oseltemivir. Diuretics, antianxiety and corticosteroids were given as supportive and symptomatic care which contributed to high mortality in hospitalized patients. Mean hospitalization period was 8.5 days. During the hospitalization, patients developed different complications i.e. 31.20% patients developed respiratory tract infections, while 17.7% patients developed ARDS and 14.4% patients developed sepsis. The mortality rate of this study population was found to be 29.1 %.
It was observed that low oxygen saturation during admission, high blood urea level, use of diuretics, corticosteroids, anti-anxiety drugs and complications like ARDS, sepsis influence the mortality rate of patients with H1N1 infection.
甲型H1N1流感(血凝素-H-神经氨酸酶-N)感染由于相关并发症及相关因素,与高发病率和死亡率相关。甲型H1N1流感患者死亡率的预测因素在极少未宣布季节性/大流行的情况下进行研究。本研究旨在描述确诊甲型H1N1流感感染患者的临床特征、并发症及影响预后的不同危险因素。
在印度马尼帕尔卡斯图尔巴医学院医院进行一项回顾性研究,分析2011年1月至2015年6月收治的141例患者的病历。
研究中的141例患者中,51.1%为女性,平均年龄32±16.2岁。92.9%的患者有发热伴头痛,78.7%的患者有咳嗽,54.6%的患者有呼吸急促。根据疾病严重程度,53.2%的患者接受了机械通气。所有患者的流感治疗均从使用奥司他韦开始。给予利尿剂、抗焦虑药和皮质类固醇作为支持性和对症治疗,这导致住院患者死亡率较高。平均住院时间为8.5天。住院期间,患者出现了不同的并发症,即31.20%的患者发生呼吸道感染,17.7%的患者发生急性呼吸窘迫综合征(ARDS),14.4%的患者发生脓毒症。该研究人群的死亡率为29.1%。
观察到入院时低氧饱和度、高血尿素水平、使用利尿剂、皮质类固醇、抗焦虑药物以及ARDS、脓毒症等并发症会影响甲型H1N1感染患者的死亡率。